A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma

NCT03234595 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent GBM

Interventions

DRUG: Cerebraca wafer

Sponsor

Everfront Biotech Co., Ltd.

Collaborators

[object Object]